Hansa Biopharma Reports First Quarter and Interim January-March 2025 Financial Results ...Middle East

Strong product sales and key progress in pipeline catalysts LUND, Sweden, April 24, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced its interim report for January-March 2025. Peter Nicklin, Chairman of the Board, Hansa Biopharma...

Hence then, the article about hansa biopharma reports first quarter and interim january march 2025 financial results was published today ( Thursday 24/04/2025 - 09:22 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma Reports First Quarter and Interim January-March 2025 Financial Results )

Also on site :

• Blessing Muzarabani ditches PSL team, joins KKR for IPL 2026
• Metal Logic Purchases Pilbara Site to Deploy Grade-Agnostic, Scalable Modular Clean Steel Smelter
• Games of the Future 2026 (Spiele der Zukunft 2026): Termine und Disziplinen für Astana bestätigt